Pulmonary Fibrosis Biomarkers Market Soars to a Valuation of US$ 6.2 Billion by 2033: Pioneering Pro
The global Pulmonary Fibrosis Biomarkers Market is on a trajectory of substantial growth, with a projected market size of US$ 4.1 billion in 2023 and an anticipated CAGR of 4.2% during the forecast period, propelling it to a valuation of US$ 6.2 billion by 2033.Key to this growth is the rapid advancement in pulmonar...